JOHNSON & JOHNSON
Mr. Sangram Kiran Pisat
SIMSREE 2017-19
Subject- Brand Analysis
INTRODUCTION - JOHNSON & JOHNSON
• Origin- America
• Founders- Robert Wood Johnson, James Wood Johnson and
Edward Mead Johnson
• Foundation year- 1886
• Headquarter- New Brunswick, New Jersey
• Consumer division- Skillman, New Jersey
• Market reach-
1. Operation- 60 countries.
2. Sale- 175 countries.
JOHNSON & JOHNSON- STRUCTURE
• Major segments of Johnson & Johnson
1. Consumer healthcare division. Ex. Baby care
2. Medical devices division. Ex. Vision care center- Vistakon
3. Pharmaceuticals division. Ex. Janssen Pharmaceutical
Range of products
STP OF JOHNSON AND JOHNSON
• Segmentation-
1. Almost all customers with income more than poverty line.
2. Family group in tier 1,2,3 cities.
• Target group-
1. Mother or whole family of new born child.
2. Health sensitive public
• Positioning-
1. Trustworthy and quality product for new born child.
2. 1st choice product for every new mother for his child.
PEST ANALYSIS OF JOHNSON & JOHNSON
• Political factors-
1. Changes in healthcare market.
2. Changes in regulation and policies of government.
3. Tax policies- J&J sells its product in 175 countries so
different tax policies affects sale of J&J in different countries.
• Economic factor-
1. It targets customer with income above poverty line so
inflation rate and exchange rates become more important.
2. Economic recession
3. Competition from natural and ayurvedic brands. Ex.
Himalaya
PEST ANALYSIS OF JOHNSON & JOHNSON
• Social factor-
1. Mouth publicity- negative and positive.
2. Different requirements of product as per body types, skin type
and trend.
3. Trust of public in the product.
• Technological factors-
1. Advancement in technology to meet new demands from
people.
2. Preparation of product to suit major type of customer
segment.
3. Use of technology and science to increase the customer
satisfaction.
SWOT ANALYSIS OF JOHNSON AND JOHNSON
• Strength-
1. Diversified products
2. Brand loyalty and brand image
3. Global sales of products
4. Introduction of health future to create awareness about health
issues.
• Weaknesses-
1. Pressure to reduce price
2. No use of natural and Ayurveda.
3. It depends highly on the revenues of Risperdal (medicine for
schizophrenia)
SWOT ANALYSIS OF JOHNSON AND JOHNSON
• Opportunity-
1. Expansion of medical devices and diagnostics.
2. Acquisition of Pfizer for growth of pharmaceutical branch.
3. Country specific products.
• Threats-
1. Ayurveda and natural companies.
2. Price competition.
ADVERTISING CAMPAIGN OF J & J
CONTROVERSIES FACED BY J&J
• 1982 Chicago Tylenol murders- Recall of 31 million bottles of
extra strength Tylenol.
• 2010 Baby products recall in NcNeil consumer healthcare
because of inability to meet manufacturing specification.
• 2010 Hip-replacement recall- DePuy recall its ASR (Artificial
Surface Replacement) hip prostheses from market. Expected
failure rate was 1% but in reality, it was 12%.
FINANCAIL ANALYSIS OF J&J
• Expected revenue growth- 3.6%
• Expected 5 year analyzed growth rate- 6.5%
• Expected earnings per share- 10.7%
• Current revenue- 71.89 billion USD
• Reasons behind expected financial growth-
1. Highly successful research in oncology treatment.
2. Launch of One Touch Via Insuline Delivery Devices.
3. Acquisition of the Abbott Medical Optics eye-surgery
equipment unit and its integration with Acuvue contact lenses.
REFERENCES
• https://en.wikipedia.org/wiki/Johnson_%26_Johnson
• http://anelecka.blogspot.in/2013/01/johnson-johnson-1.html
• https://www.fool.com/investing/2016/10/12/can-johnson-
johnson-keep-growing-healthier.aspx
THANK YOU !!!

Johnson & Johnson by sangram pisat

  • 1.
    JOHNSON & JOHNSON Mr.Sangram Kiran Pisat SIMSREE 2017-19 Subject- Brand Analysis
  • 2.
    INTRODUCTION - JOHNSON& JOHNSON • Origin- America • Founders- Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson • Foundation year- 1886 • Headquarter- New Brunswick, New Jersey • Consumer division- Skillman, New Jersey • Market reach- 1. Operation- 60 countries. 2. Sale- 175 countries.
  • 3.
    JOHNSON & JOHNSON-STRUCTURE • Major segments of Johnson & Johnson 1. Consumer healthcare division. Ex. Baby care 2. Medical devices division. Ex. Vision care center- Vistakon 3. Pharmaceuticals division. Ex. Janssen Pharmaceutical Range of products
  • 4.
    STP OF JOHNSONAND JOHNSON • Segmentation- 1. Almost all customers with income more than poverty line. 2. Family group in tier 1,2,3 cities. • Target group- 1. Mother or whole family of new born child. 2. Health sensitive public • Positioning- 1. Trustworthy and quality product for new born child. 2. 1st choice product for every new mother for his child.
  • 5.
    PEST ANALYSIS OFJOHNSON & JOHNSON • Political factors- 1. Changes in healthcare market. 2. Changes in regulation and policies of government. 3. Tax policies- J&J sells its product in 175 countries so different tax policies affects sale of J&J in different countries. • Economic factor- 1. It targets customer with income above poverty line so inflation rate and exchange rates become more important. 2. Economic recession 3. Competition from natural and ayurvedic brands. Ex. Himalaya
  • 6.
    PEST ANALYSIS OFJOHNSON & JOHNSON • Social factor- 1. Mouth publicity- negative and positive. 2. Different requirements of product as per body types, skin type and trend. 3. Trust of public in the product. • Technological factors- 1. Advancement in technology to meet new demands from people. 2. Preparation of product to suit major type of customer segment. 3. Use of technology and science to increase the customer satisfaction.
  • 7.
    SWOT ANALYSIS OFJOHNSON AND JOHNSON • Strength- 1. Diversified products 2. Brand loyalty and brand image 3. Global sales of products 4. Introduction of health future to create awareness about health issues. • Weaknesses- 1. Pressure to reduce price 2. No use of natural and Ayurveda. 3. It depends highly on the revenues of Risperdal (medicine for schizophrenia)
  • 8.
    SWOT ANALYSIS OFJOHNSON AND JOHNSON • Opportunity- 1. Expansion of medical devices and diagnostics. 2. Acquisition of Pfizer for growth of pharmaceutical branch. 3. Country specific products. • Threats- 1. Ayurveda and natural companies. 2. Price competition.
  • 9.
  • 10.
    CONTROVERSIES FACED BYJ&J • 1982 Chicago Tylenol murders- Recall of 31 million bottles of extra strength Tylenol. • 2010 Baby products recall in NcNeil consumer healthcare because of inability to meet manufacturing specification. • 2010 Hip-replacement recall- DePuy recall its ASR (Artificial Surface Replacement) hip prostheses from market. Expected failure rate was 1% but in reality, it was 12%.
  • 11.
    FINANCAIL ANALYSIS OFJ&J • Expected revenue growth- 3.6% • Expected 5 year analyzed growth rate- 6.5% • Expected earnings per share- 10.7% • Current revenue- 71.89 billion USD • Reasons behind expected financial growth- 1. Highly successful research in oncology treatment. 2. Launch of One Touch Via Insuline Delivery Devices. 3. Acquisition of the Abbott Medical Optics eye-surgery equipment unit and its integration with Acuvue contact lenses.
  • 12.
    REFERENCES • https://en.wikipedia.org/wiki/Johnson_%26_Johnson • http://anelecka.blogspot.in/2013/01/johnson-johnson-1.html •https://www.fool.com/investing/2016/10/12/can-johnson- johnson-keep-growing-healthier.aspx
  • 13.